The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis.
about
Contrast-enhanced computerized tomography combined with a targeted nanoparticle contrast agent for screening for early-phase non-small cell lung cancer.Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways.MACC‑1 antibody target therapy suppresses growth and migration of non‑small cell lung cancer.FGFR1 gene amplification in squamous cell carcinomas of the lung: a potential favorable prognostic marker for women and for patients with advanced cancer.FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.
P2860
The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The clinical pathological char ...... lung cancer: a meta-analysis.
@ast
The clinical pathological char ...... lung cancer: a meta-analysis.
@en
type
label
The clinical pathological char ...... lung cancer: a meta-analysis.
@ast
The clinical pathological char ...... lung cancer: a meta-analysis.
@en
prefLabel
The clinical pathological char ...... lung cancer: a meta-analysis.
@ast
The clinical pathological char ...... lung cancer: a meta-analysis.
@en
P2093
P2860
P356
P1476
The clinical pathological char ...... lung cancer: a meta-analysis.
@en
P2093
Fa-Jun Xie
Hong-Yang Lu
Qiu-Qing Zheng
Wei-Min Mao
Yi-Ping Zhang
P2860
P304
P356
10.2147/OTT.S91848
P407
P577
2016-01-06T00:00:00Z